Related Experiment Video
Updated: May 23, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Modulation of PAR(1) signalling by benzimidazole compounds
S Asteriti1, S Daniele, F Porchia
1Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Italy.
New benzimidazole derivatives, Q94 and Q109, selectively modulate PAR(1) signaling. These compounds offer a novel scaffold for developing PAR(1) inhibitors and modulators targeting specific pathways.
Area of Science:
- Pharmacology
- Cellular Biology
- Biochemistry
Background:
- A small molecule, Q94, was identified to selectively inhibit the interaction and signaling between PAR(1) and Gα(q).
- This study investigates the pharmacological properties of Q94 and two related benzimidazole analogues, Q109 and Q89.
Purpose of the Study:
- To characterize the pharmacological effects of Q94, Q109, and Q89 on PAR(1) signaling pathways.
- To evaluate the selectivity of these compounds for PAR(1) over PAR(2).
- To explore the potential of these benzimidazole derivatives as modulators of PAR(1) activity.
Main Methods:
- Assessed intracellular calcium (Ca2+) mobilization and inositol 1,4,5-trisphosphate accumulation in human microvascular endothelial cells.
- Measured isoprenaline- or forskolin-stimulated cAMP production in response to thrombin.
- Utilized receptor-specific activating peptides to confirm PAR(1) selectivity.
Main Results:
- Q94 and Q109 (10 µM) significantly reduced thrombin-induced intracellular Ca2+ mobilization and inositol 1,4,5-trisphosphate production, indicating inhibition of Gα(q) signaling.
- These compounds selectively targeted PAR(1), as demonstrated by their lack of effect on PAR(2) activation.
- The results suggest that Q94 and Q109 act as 'allosteric agonists' of PAR(1), modulating its activity.
Conclusions:
- The benzimidazole derivatives Q94 and Q109 represent a novel scaffold for developing PAR(1) inhibitors.
- These compounds provide a foundation for creating dual signaling pathway-selective positive and negative modulators of PAR(1).
- Further development could lead to targeted therapeutics for conditions involving PAR(1) dysregulation.
Related Concept Videos
Anthelminthic Agents
NMR Spectroscopy of Benzene Derivatives
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Paracrine Signaling
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Gene Regulation in Microbial Communities: Quorum Sensing

